Invited talks and podium presentations – Seda https://www.sedapds.com Tue, 19 Nov 2024 10:03:41 +0000 en-GB hourly 1 Clinically-relevant dissolution specifications, implication for use in the post-approval setting & tension with F2 similarity testing https://www.sedapds.com/presentation/clinically-relevant-dissolution-specifications-implication-for-use-in-the-post-approval-setting-tension-with-f2-similarity-testing/?utm_source=rss&utm_medium=rss&utm_campaign=clinically-relevant-dissolution-specifications-implication-for-use-in-the-post-approval-setting-tension-with-f2-similarity-testing Tue, 19 Nov 2024 10:02:19 +0000 https://www.sedapds.com/?post_type=presentation&p=2286 The post Clinically-relevant dissolution specifications, implication for use in the post-approval setting & tension with F2 similarity testing appeared first on Seda.

]]> The post Clinically-relevant dissolution specifications, implication for use in the post-approval setting & tension with F2 similarity testing appeared first on Seda.

]]> Transforming promising molecules into valued medicines – the emerging Alderley Park Translational Science Ecosytem (APTrans) https://www.sedapds.com/presentation/transforming-promising-molecules-into-valued-medicines-the-emerging-alderley-park-translational-science-ecosytem-aptrans/?utm_source=rss&utm_medium=rss&utm_campaign=transforming-promising-molecules-into-valued-medicines-the-emerging-alderley-park-translational-science-ecosytem-aptrans Wed, 31 Jan 2024 17:40:58 +0000 https://www.sedapds.com/?post_type=presentation&p=2125 The post Transforming promising molecules into valued medicines – the emerging Alderley Park Translational Science Ecosytem (APTrans) appeared first on Seda.

]]> The post Transforming promising molecules into valued medicines – the emerging Alderley Park Translational Science Ecosytem (APTrans) appeared first on Seda.

]]> Design space considerations for dissolution methods https://www.sedapds.com/presentation/design-space-considerations-for-dissolution-methods/?utm_source=rss&utm_medium=rss&utm_campaign=design-space-considerations-for-dissolution-methods Wed, 31 Jan 2024 17:39:51 +0000 https://www.sedapds.com/?post_type=presentation&p=2124 The post Design space considerations for dissolution methods appeared first on Seda.

]]> The post Design space considerations for dissolution methods appeared first on Seda.

]]> Accelerating the development of drug products using advanced pharmaceutical design tools and manufacturing https://www.sedapds.com/presentation/accelerating-the-development-of-drug-products-using-advanced-pharmaceutical-design-tools-and-manufacturing/?utm_source=rss&utm_medium=rss&utm_campaign=accelerating-the-development-of-drug-products-using-advanced-pharmaceutical-design-tools-and-manufacturing Wed, 31 Jan 2024 17:39:01 +0000 https://www.sedapds.com/?post_type=presentation&p=2123 The post Accelerating the development of drug products using advanced pharmaceutical design tools and manufacturing appeared first on Seda.

]]> The post Accelerating the development of drug products using advanced pharmaceutical design tools and manufacturing appeared first on Seda.

]]> Pharmaceutical Quality: The dissolution test and clinically relevant specifications – impact on product development https://www.sedapds.com/presentation/pharmaceutical-quality-the-dissolution-test-and-clinically-relevant-specifications-impact-on-product-development/?utm_source=rss&utm_medium=rss&utm_campaign=pharmaceutical-quality-the-dissolution-test-and-clinically-relevant-specifications-impact-on-product-development Wed, 31 Jan 2024 17:37:55 +0000 https://www.sedapds.com/?post_type=presentation&p=2122 The post Pharmaceutical Quality: The dissolution test and clinically relevant specifications – impact on product development appeared first on Seda.

]]> The post Pharmaceutical Quality: The dissolution test and clinically relevant specifications – impact on product development appeared first on Seda.

]]> Clinically relevant specifications in practice: What have we learned since the QbD Pilot Program? https://www.sedapds.com/presentation/clinically-relevant-specifications-in-practice-what-have%e2%80%afwe-learned-since-the-qbd-pilot-program/?utm_source=rss&utm_medium=rss&utm_campaign=clinically-relevant-specifications-in-practice-what-have%25e2%2580%25afwe-learned-since-the-qbd-pilot-program Wed, 31 Jan 2024 17:36:46 +0000 https://www.sedapds.com/?post_type=presentation&p=2121 The post Clinically relevant specifications in practice: What have we learned since the QbD Pilot Program? appeared first on Seda.

]]> The post Clinically relevant specifications in practice: What have we learned since the QbD Pilot Program? appeared first on Seda.

]]> Introduction to the Biopharmaceutics Risk Assessment Roadmap (BioRAM), Drug Delivery Scenarios and Scoring Grid https://www.sedapds.com/presentation/introduction-to-the-biopharmaceutics-risk-assessment-roadmap-bioram-drug-delivery-scenarios-and-scoring-grid/?utm_source=rss&utm_medium=rss&utm_campaign=introduction-to-the-biopharmaceutics-risk-assessment-roadmap-bioram-drug-delivery-scenarios-and-scoring-grid Wed, 31 Jan 2024 17:15:25 +0000 https://www.sedapds.com/?post_type=presentation&p=2120 The post Introduction to the Biopharmaceutics Risk Assessment Roadmap (BioRAM), Drug Delivery Scenarios and Scoring Grid appeared first on Seda.

]]> The post Introduction to the Biopharmaceutics Risk Assessment Roadmap (BioRAM), Drug Delivery Scenarios and Scoring Grid appeared first on Seda.

]]> Score sheet, Box 1: Early basic knowledge, starting point.  From Blueprint to action: Getting to critical questions and knowledge. https://www.sedapds.com/presentation/score-sheet-box-1-early-basic-knowledge-starting-point-%e2%80%af-from-blueprint-to-action-getting-to-critical-questions-and-knowledge/?utm_source=rss&utm_medium=rss&utm_campaign=score-sheet-box-1-early-basic-knowledge-starting-point-%25e2%2580%25af-from-blueprint-to-action-getting-to-critical-questions-and-knowledge Wed, 31 Jan 2024 17:14:30 +0000 https://www.sedapds.com/?post_type=presentation&p=2119 The post Score sheet, Box 1: Early basic knowledge, starting point.  From Blueprint to action: Getting to critical questions and knowledge. appeared first on Seda.

]]> The post Score sheet, Box 1: Early basic knowledge, starting point.  From Blueprint to action: Getting to critical questions and knowledge. appeared first on Seda.

]]> In silico modelling: Subcutaneous Bioavailability of mAbs https://www.sedapds.com/presentation/in-silico-modelling-subcutaneous-bioavailability-of-mabs/?utm_source=rss&utm_medium=rss&utm_campaign=in-silico-modelling-subcutaneous-bioavailability-of-mabs Wed, 31 Jan 2024 17:12:05 +0000 https://www.sedapds.com/?post_type=presentation&p=2117 The post In silico modelling: Subcutaneous Bioavailability of mAbs appeared first on Seda.

]]> The post In silico modelling: Subcutaneous Bioavailability of mAbs appeared first on Seda.

]]> Biopharmaceutics in Complex Parenteral Formulation Design https://www.sedapds.com/presentation/biopharmaceutics-in-complex-parenteral-formulation-design/?utm_source=rss&utm_medium=rss&utm_campaign=biopharmaceutics-in-complex-parenteral-formulation-design Wed, 31 Jan 2024 17:08:50 +0000 https://www.sedapds.com/?post_type=presentation&p=2116 The post Biopharmaceutics in Complex Parenteral Formulation Design appeared first on Seda.

]]> The post Biopharmaceutics in Complex Parenteral Formulation Design appeared first on Seda.

]]>